• ALOGLIPTIN chembl:CHEMBL376359 Approved

    Alternate Names:

    VIPIDIA
    ALOGLIPTIN
    VIPIDIA®
    ALOGLIPTINUM
    ALOGLIPTINA
    NESINA®
    ALOGLIPTINE
    SYR-322
    chembl:CHEMBL376359
    drugbank:06203
    pubchem.compound:11450633
    chemidplus:850649-61-5
    rxcui:1368001

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antidiabetic
    (0 More Sources)

    Publications:

  • Interaction Score: 5.15

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name alogliptin, SYR-322,Nesina

    PMIDs:
    None found


    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antidiabetic
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0NJ5H TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: